Infective endocarditis in two patients with pemphigus vulgaris under multiagent immunosuppressive drug therapy: A rare entity to remember in the differential diagnosis of fever of unknown origin-Reference-Cited by-同舟云学术

Infective endocarditis in two patients with pemphigus vulgaris under multiagent immunosuppressive drug therapy: A rare entity to remember in the differential diagnosis of fever of unknown origin

Published:2019-02-27 Issue:3 Volume:32 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Küçükoğlu Rıfkiye¹,Kılıç Sıla¹^ORCID,Sun Gizem Pınar¹

Affiliation:

1. Department of Dermatology and VenereologyIstanbul Faculty of Medicine, Istanbul University Istanbul Turkey

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12860

Reference13 articles.

1. Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin

2. ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). (2015). Endorsed by: European Association for Cardio‐Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM);Habib G.;European Heart Journal,2015

3. Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

4. Infective endocarditis in a patient with lupus nephritis who was undergoing immunosuppressive therapy: A case of survival

5. Long‐term immunesuppressive treatment of pemphigus vulgaris as a predisposing factor for native valve endocarditis: Report of two cases;Kayrak M.;The Journal of Heart Valve Disease,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of combined use of prednisone and immunosuppressive therapy in patients with systemic lupus erythematosus, and its influence on incidence of adverse reactions;Tropical Journal of Pharmaceutical Research;2022-08-10

2. Clinical and biological activity of rituximab in the treatment of pemphigus;Immunotherapy;2021-01

3. Immunosuppressants;Reactions Weekly;2019-07